ACCESS Newswire

MicroVision, Inc.

26.7.2021 22:11:48 CEST | ACCESS Newswire | Press release

Share
MicroVision Hires Dr. Thomas Luce to Lead EMEA Business Development and Announces Opening of Germany Office

REDMOND, WA / ACCESSWIRE / July 26, 2021 / MicroVision, Inc. (NASDAQ:MVIS), a leader in MEMS based solid state automotive lidar and micro-display technology for augmented reality, today announced the hiring of Dr. Thomas Luce as Vice President of Business Development, focused on European and Middle East markets, as well as plans to open a new office in Germany to help promote the Company's automotive lidar technology and sensor to OEMs and Tier 1 suppliers.

"As interest in our lidar technology grows, our presence in Germany allows us to work more closely with potential partners and customers," said Sumit Sharma, MicroVision's Chief Executive Officer. "I am thrilled that Dr. Luce will lead our business development efforts in Europe and the Middle East. Based on the data we have shared to date with OEMs and mobility-as-a-service companies, a local presence will help us work closely to ensure that our LRL sensor meets or exceeds target OEM and Tier 1 expectations. Initial feedback from potential partners and customers has been positive. I am happy about our progress so far. With COVID restrictions lifting and staff starting to return to the office, we look forward to our team moving to track testing of our sensor."

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

Joining MicroVision on September 1, 2021, Dr. Luce is a seasoned executive with more than 25 years of experience in Automotive Lighting and Optics. He held various leadership roles at Philips Automotive Lighting, Schefenacker, Valeo and Eschenbach Optik. Most recently, he served as CEO for Optoflux GmbH, where he grew the company into a global automotive and optics company, adding LED and lidar optics to the company portfolio. With an extensive career in the automotive area, he has deep insight into the automotive sensor and lighting community. He studied Physics and Chemistry at Heidelberg and Berlin University, as well as Business Administration at Hagen. He earned his PhD with great honor in nonlinear optics at Free University Berlin.

"I am thrilled by the opportunity to join the MicroVision team and to develop the MicroVision business in Europe," said Dr. Luce. "I believe that especially the premium car manufacturers are now strongly pushing for autonomous driving, and I am convinced that the lidar solution MicroVision could provide to its Automotive customers will be an enabler for autonomy and safety for the future. I see a huge potential to capture a significant share of the lidar sensor market and to create value for MicroVision's shareholders."

About MicroVision

MicroVision is a pioneering company in MEMS based laser beam scanning technology that integrates MEMS, lasers, optics, hardware, algorithms and machine learning software into its proprietary technology to address existing and emerging markets. The Company's integrated approach uses its proprietary technology to provide solutions for automotive lidar sensors, augmented reality micro-display engines, interactive display modules and consumer lidar modules.

For more information, visit the Company's website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc or follow MicroVision on Twitter at @MicroVision.

MicroVision is a trademark of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.

Forward-Looking Statements

Certain statements contained in this release, including those related to the Company's opening of a new office, engaging with potential partners and customers, market opportunity, product features, solutions and applications and building value for shareholders are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include the risk that the Company may not succeed in finding licensing or other strategic solutions, including a potential sale of the Company, with acceptable timing, benefits or costs; its ability to operate with limited cash or to raise additional capital when needed; market acceptance of its technologies and products or for products incorporating its technologies; the failure of its commercial partners to perform as expected under its agreements, including from the impact of COVID-19 (coronavirus); its ability to identify parties interested in paying any amounts or amounts that the Company deems desirable for the purchase or license of intellectual property assets; its or its customers' failure to perform under open purchase orders; its financial and technical resources relative to those of its competitors; its ability to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual property rights and protect its proprietary technologies; the ability to obtain additional contract awards and develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to maintain its listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company's SEC reports, including the Company's Annual Report on Form 10-K filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.

Investor Relations Contact

David H. Allen
Darrow Associates, Inc.
408.427.4463
dallen@darrowir.com

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

SOURCE: MicroVision, Inc.



View source version on accesswire.com:
https://www.accesswire.com/657076/MicroVision-Hires-Dr-Thomas-Luce-to-Lead-EMEA-Business-Development-and-Announces-Opening-of-Germany-Office

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

ComplianceQuest and Zolon PCS Selected to Modernize U.S. Food and Drug Administration (FDA) Enterprise Quality Management System6.10.2026 18:00:00 CEST | Press release

TAMPA, FL / ACCESS Newswire / October 6, 2026 / ComplianceQuest, a leading provider of AI-powered connected Quality, Risk and Compliance (QRC) systems, and Zolon PCS, a provider of secure, mission-focused IT services to federal agencies, today announced that the U.S. Food and Drug Administration (FDA) will modernize its enterprise quality management operations on the ComplianceQuest platform. The initiative will be delivered under the FDA Cloud Quality Management System Blanket Purchase Agreement (BPA), a five-year agreement awarded to Zolon PCS as prime contractor, with ComplianceQuest as its platform partner. Together, ComplianceQuest and Zolon PCS will help FDA implement a modern, secure, AI-enabled quality management solution built on the Salesforce FedRAMP Government Cloud platform. The solution is designed to strengthen compliance, improve consistency, streamline quality processes, and deliver greater insight across FDA's centers and offices. The initiative will focus on four pri

Stagwell Launches New Global Media Agency, Stagwell Media6.10.2026 15:45:00 CEST | Press release

NEW YORK CITY, NY / ACCESS Newswire / October 6, 2026 / Stagwell (NASDAQ:STGW), the global challenger network transforming marketing through AI, today announced the launch of Stagwell Media, its global media agency that delivers performance built to unlock ambition. The name Stagwell Media marks a new approach to media building on the Assembly agency, bringing together its performance heritage and ecosystem expertise while debuting a new agile, integrated model powered by next generation agentic technology, Stagwell's Machine OS. Designed for the rapidly changing media landscape, Stagwell Media delivers performance with the speed, flexibility and intelligence required to succeed in a world where brands must engage priority audiences while influencing the agentic systems that shape discovery, recommendation and activation.By transforming media into a more connected and adaptive growth engine, the agency empowers brands to unlock greater ambition and drive stronger business results. "The

Valsoft Corporation Announces Acquisition of the Firebrand Group Collection of Companies6.10.2026 14:50:00 CEST | Press release

MONTRÉAL, QC / ACCESS Newswire / October 6, 2026 / Valsoft Corporation Inc. ("Valsoft"), a Montreal-based company specializing in the acquisition and development of vertical market software businesses, today announced the acquisition of ​​Firebrand Technologies ("Firebrand"), NetGalley LLC ("NetGalley"), and Supadu Ltd ("Supadu"), together known as ​the ​Firebrand Group, a global collection of companies providing leading software and services that help publishers succeed. Valsoft acquired the Firebrand Group from Media Do International, the US-based subsidiary of MEDIA DO Ltd., in Japan. Founded in 1987 and headquartered in Newburyport, Massachusetts, Firebrand​ Technologies​ provides title management and metadata software publishers use to plan, manage, and distribute book data to retailers and trading partners around the world. Its ​flagship ​​ ​platform, Title Management Enterprise, runs the publishing workflow from acquisition through publication, keeping schedules, rights, costs,

U.S. Polo Assn. Celebrates an Outstanding 2026 European Polo Season6.10.2026 13:00:00 CEST | Press release

WEST PALM BEACH, FL / ACCESS Newswire / October 6, 2026 / U.S. Polo Assn.®, the official sports brand of the United States Polo Association (USPA), supported several major sports events across Europe during the 2026 summer season, reinforcing the brand's authentic connection to the sport across the continent. U.S. Polo Assn. served as the Official Apparel and Jersey Sponsor for multiple events, including:55th Sotogrande International Polo Tournament at Ayala Polo Club in Sotogrande, Spain;Barnes French Open at Polo Club de Chantilly in France;Engel & Völkers Berlin Maifeld Polo Cup in Germany;Museumplein Polo Amsterdam in the Netherlands; Barnes French Open Winners, Kazak, on stage with trophy at Polo Club de Chantilly in France Across these partnerships, U.S. Polo Assn. outfitted players, umpires, and event staff while supporting competition ranging from historic high-goal championships in iconic venues throughout the region. "U.S. Polo Assn.'s presence across Europe reflects both the

Synexis and Customate Collaborate to Advance Continuous Indoor Pathogen Control for the U.K. Poultry Industry5.10.2026 22:10:00 CEST | Press release

OVERLAND PARK, KS AND YORKSHIRE, ENGLAND / ACCESS Newswire / October 5, 2026 / Synexis®, LLC, the leader in touchless, continuous pathogen control technology, has announced a strategic collaboration with Customate Solutions, a family-owned engineering company and trusted provider of innovative manufacturing solutions with deep expertise across the poultry industry. The collaboration will bring Synexis patented DHP® technology to poultry producers throughout the United Kingdom and Ireland, helping hatcheries, poultry farms, processing facilities, and related operations strengthen indoor pathogen control while supporting modern biosecurity strategies. Poultry producers today face increasing pressure to maximize healthy hatch rates, improve chick quality, and strengthen biosecurity while reducing operational risk. Bacterial contamination on hatching eggs and throughout hatchery environments can directly impact hatchability, flock health, and production performance, making effective pathog

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye